Farydak (panobinostat) Capsules
Generic name : Panobinostat.
Trade name : Farydak.
Manufacturer name :
Farydak” is manufactured by Novartis Pharmaceuticals Corporation.
Farydak FDA Approval :
Farydak first approved February 23rd, 2015.
Dosage form :
Capsules: 10 mg, 15 mg, and 20 mg.
Indications and usage :
- Multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent.
- Relapsed and refractory multiple myeloma.
Farydak (Panobinostat) Capsules availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.